PCML
NUVB icon

Pavaki Capital Management LLC’s Nuvation Bio NUVB Stock Holding History

Pavaki Capital Management LLC’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$170K Hold
30,000
– – 0.06% 137
2026
Q1 		$129K Buy
+30,000
New +$167K 0.05% 142

Other funds holding NUVB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return

Pavaki Capital Management LLC's NUVB Position: Q2 2026 in Review

Pavaki Capital Management LLC held its Nuvation Bio (NUVB) position steady in Q2 2026 at 30,000 shares worth $170K. The position accounts for 0.06% of the portfolio, ranked #137.

Pavaki Capital Management LLC first reported a position in NUVB in Q1 2026 and has held it in 2 quarters since. 84 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Pavaki Capital Management LLC held 30,000 shares of Nuvation Bio worth $170K as of Q2 2026.
  • Pavaki Capital Management LLC left its Nuvation Bio share count unchanged in Q2 2026.
  • Nuvation Bio made up 0.06% of Pavaki Capital Management LLC's portfolio in Q2 2026, its #137 holding.
  • Pavaki Capital Management LLC first reported a position in Nuvation Bio in Q1 2026 and has held it in 2 quarters since.
  • 84 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Pavaki Capital Management LLC's 13F filing for Q2 2026, filed 7 Aug 2026.